GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
MENLO PARK, Calif., Nov. 4, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that